Schedule 13G ownership disclosure
SINGULAR GENOMICS SYSTEMS IN
Common Stock par value $0.0001 per share · CUSIP: 82933R308
Event date: 2025-02-21
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ARCH Venture Fund IX, L.P.
Shares: 0.00 · Class: 0%
- ARCH Venture Partners IX, L.P.
Shares: 0.00 · Class: 0%
- ARCH Venture Partners IX, LLC
Shares: 0.00 · Class: 0%
- Keith Crandell
Shares: 0.00 · Class: 0%
- Clinton Bybee
Shares: 0.00 · Class: 0%
- Robert Nelsen
Shares: 0.00 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-25-000406
- Form type
- SCHEDULE 13G/A
- Filer
- ARCH Venture Fund IX, L.P.
- CIK
- CIK 1666306
- Filed
- May 15, 2025
- Reporting period
- Feb 21, 2025
- Description
- Schedule 13G beneficial ownership